newsfilter
← Latest News
Business Wire·

Concert Pharmaceuticals Reports First Quarter 2022 Financial Results

Phase 3 Data Readout in Alopecia Areata Expected Second Quarter of 2022 Alopecia Areata Represents Significant Market Opportunity with Important Medical Need Conference Call Scheduled Today at 8:30 a.m. ET Concert Pharmaceuticals, Inc. (NASDAQ: